Diary - News
All news Adocia announces the transformation of its business model
• With its experience on BioChaperone® Lispro, Adocia intends to develop its projects further, at least to Phase 3
• Three new projects targeting major markets are expected to enter clinical trials this year
• Adocia’s portfolio of projects is one of the most differentiated in the industry with a particular focus on improving treatment for people with type 1 diabetes
• Adocia’s innovation strategy based on the reformulation of already approved proteins is reinforced by the current economic environment which imposes constraints on the price of medicine
